A new study explores gene editing to treat Stargardt disease, a rare genetic eye condition causing vision loss. Researchers used a base editor to correct the ABCA4 gene mutation in mice and primates. While promising, human trials are needed to confirm efficacy and address cost concerns. India also faces this inherited disease, highlighting a need for gene therapy advancements.
